The University of Chicago Header Logo

Medications for Multiple Sclerosis and Risk of Malignancy: What Next?

Medications for Multiple Sclerosis and Risk of Malignancy: What Next? Neurotherapeutics. 2021 07; 18(3):1650-1653.

View in: PubMed